• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioLine RX Ltd

+ Add to Watchlist

BLRX:US

1.7400 USD 0.0100 0.58%

As of 20:10:00 ET on 12/17/2014.

Snapshot for BioLine RX Ltd (BLRX)

Open: 1.7700 Day's Range: 1.6900 - 1.7800 Volume: 357,227
Previous Close: 1.7300 52wk Range: 1.2000 - 3.1200 1-Yr Rtn: -37.18%

Stock Chart for BLRX

No chart data available.
  • BLRX:US 1.7400
  • 1D
  • 1M
  • 1Y
1.7300
Interactive BLRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (ILS) (ttm) -
Est. EPS (ILS) (12/2014) -1.5480
Est. PEG Ratio -
Market Cap (M USD) 59.10
Shares Outstanding (M) 33.96
30 Day Average Volume 286,013
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLRX

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BLRX

BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.

Kinneret Livnat SavitskyChief Executive OfficerPhilip SerlinCFO/COO
David MalekVP:Business DevelopmentArnon AharonVP:Medical Affairs
More Company Profile & Key Executives for BLRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil